NLRP1 and neoplasm: In summary, we identified a novel pathway at the RNA level with potential relevance for the development and treatment of cSCCs, but also of other types of tumors, namely the regulation of NLRP1 mRNA expression through p62 mRNA, which is mediated by miR-34a-5p, an established tumor suppressor in different tissues.